The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinomaJeffrey E. Green, Christine Couldrey, Masaaki Shibata et al.|Oncogene|2000Cited by 265
Immunotherapy of cancer by IL-12-based cytokine combinationsJonathan M. Weiss, Robert H. Wiltrout, Jeffrey Subleski et al.|Expert Opinion on Biological Therapy|2007Cited by 223
Administration of Interleukin 12 With Pulse Interleukin 2 and the Rapid and Complete Eradication of Murine Renal CarcinomaJon M. Wigginton, Robert H. Wiltrout, Timothy Back et al.|JNCI Journal of the National Cancer Institute|1996Cited by 160
Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged miceAnnie Mirsoian, William J. Murphy, Myriam N. Bouchlaka et al.|The Journal of Experimental Medicine|2014Cited by 138
IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapyJon M. Wigginton, Robert H. Wiltrout, Eilene Gruys et al.|Journal of Clinical Investigation|2001Cited by 126